Drug Design


Drug design, habitually stated to as rational drug design or simply rational design, is the inventive process of finding new medications based on the knowledge of a biological target. The drug is utmost commonly an organic trivial molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most fundamental sense, drug design encompasses the design of molecules that are complementary in shape and charge to the biomolecular target with which they interact and therefore will bind to it. Drug design seldom but not inevitably relies on computer modeling techniques. This type of sculpting is sometimes bring up to as computer-aided drug design. Finally, drug design that relies on the acquaintance of the three-dimensional erection of the biomolecular target is known as structure-based drug design.


  • Drug targets
  • Virtual Screening

Related Conference of Drug Design

June 25-26, 2024

13th World Congress on Chromatography

Toronto, Canada
August 22-23, 2024

16th International Conference on Clinical Chemistry

Berlin, Germany
October 14-15, 2024

4th International Conference on Analytical Chemistry

Barcelona, Spain
November 13-14, 2024

5th World Expo on Biopolymers and Bioplastics

Dubai, UAE
December 12-13, 2024

23rd World Congress on Nutrition and Food Chemistry

Rome, Italy
December 18-19, 2024

4th International Conference on Petrochemistry and Natural Gas

Amsterdam, Netherlands

Drug Design Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in